Buchang Pharmaceutical announced that Luzhou Buchang, a holding subsidiary of the company, plans to invest 40 million yuan in cash from its own capital to establish Hangzhou Buchang New Drug Research and Development Co., Ltd., with a 100% shareholding ratio. The company held the 57th meeting of the 5th board of directors on September 29, 2026 to review and approve the matter, and there is no need to submit it to the shareholders' meeting for consideration.

Zhitongcaijing · 1d ago
Buchang Pharmaceutical announced that Luzhou Buchang, a holding subsidiary of the company, plans to invest 40 million yuan in cash from its own capital to establish Hangzhou Buchang New Drug Research and Development Co., Ltd., with a 100% shareholding ratio. The company held the 57th meeting of the 5th board of directors on September 29, 2026 to review and approve the matter, and there is no need to submit it to the shareholders' meeting for consideration.